Reporting Manager
Seven Fleet Master Fund LP
Symbol
CTMX
Disclosed Ownership
48,898 shares
Ownership
0.02%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 12:04:30 UTC
Date of event
30 Sep 2025

Sponsored

Quoteable Key Fact

"Seven Fleet Capital Management LP disclosed 0.02% ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX) on 30 Sep 2025."

Quick Takeaways

  • Seven Fleet Capital Management LP filed SCHEDULE 13G/A for CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX).
  • Disclosed ownership: 0.02%.
  • Date of event: 30 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Nov 2025, 12:04.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Seven Fleet Master Fund LP 0.02% 48,898 0 48,898 /s/ Dr. Brian Liu Dr. Brian Liu, Managing Member of Seven Fleet Capital Management LP, its Investment Mgr and Seven Fleet Capital Management GP, LLC, its Gen'l Ptr
Seven Fleet Capital Management LP 0.02% 48,898 0 48,898 /s/ Dr. Brian Liu Dr. Brian Liu , Managing Member of Seven Fleet Capital Management GP, LLC, its General Partner
Seven Fleet Capital Management GP LLC 0.02% 48,898 0 48,898 /s/ Dr. Brian Liu Dr. Brian Liu, Managing Member
Brian Liu 0.02% 48,898 0 48,898 /s/ Dr. Brian Liu Dr. Brian Liu